Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 2801 - 2808 of 12107 results

Discretion Retained: USPTO Dodges Attack from Big Tech to Rein in Discretionary IPR Denials
November 22, 2021| Blog| Viewpoint

Who’s in Charge Here? Federal Circuit Says An Arbitrator, not District Court, Should Decide Arbitrability
November 22, 2021| Blog| Viewpoint

OSHA Vaccine Rule Blocked Permanently by Fifth Circuit, But Judicial Review Will Continue
November 19, 2021| Blog| Viewpoint

About Face: Laboratory-Developed Tests for COVID-19 Now Subject to EUA Requirements
November 19, 2021| Blog| Viewpoint

Mintz Lawyer’s New Book Puts 11 Faces on America’s Immigration ‘Crisis’
November 19, 2021| News

New York Significantly Expands its Whistleblower Law
November 19, 2021| Blog| Viewpoint

Examining Art Units to Avoid Subject Matter Eligibility Challenges for Bioinformatics and AI-related Patents
November 18, 2021| Blog| Viewpoint

Should Employers Keep Preparing for the COVID-19 ETS?
November 16, 2021| News
News & Press Releases
Mintz Honored with NLADA Beacon of Justice Award
August 21, 2025
Mintz will receive a 2025 Beacon of Justice Award from the National Legal Aid & Defender Association (NLADA) for efforts to sustain equal justice for families and communities. This is the sixth consecutive year that Mintz has won this award.
SEC’s Pharmaceutical Insider Trading Case Yields Quick Deals
August 19, 2025
Bloomberg Law featured a statement from Member Jason P.W. Halperin in its coverage of a pharmaceutical insider trading case brought by the SEC. Jason and the Mintz team of Sean Prosser and Elizabeth Platonova represented Robert Yedid in reaching a resolution in which the client pled guilty and, along with the other defendants, entered into consent orders with the SEC.
Mintz Advises Oppenheimer & Co. and Initial Purchasers in $475M Convertible Senior Notes Offering by WisdomTree
August 19, 2025
Mintz represented Oppenheimer & Co., as sole book-running manager, and Craig-Hallum Capital Group and Northland Securities, as co-managers, in the private placement of $475 million aggregate principal amount of 4.625% Convertible Senior Notes due 2030 issued by WisdomTree, Inc (NYSE: WT) (“WisdomTree”). The notes were sold to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933.
Events
Podcasts

Mintz On Air: Practical Policies - Investigations Unscripted
August 12, 2025| Podcast|

Mintz On Air: Practical Policies — A Private Equity Non-Compete Primer
July 15, 2025| Podcast|

Health Law Diagnosed – Best Practices for Communicating with the FDA
July 9, 2025| Podcast|
